Skip to main navigation Skip to search Skip to main content

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)S63-S63
JournalJournal of the Neurological Sciences
Volume238
Publication statusPublished - 1 Jan 2005

Cite this